(Q44158595)

30 November 2017

title

Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures (English)

1 reference

30 November 2017

Raffaella Carpenedo

1

1 reference

30 November 2017

Elena Meli

2

1 reference

30 November 2017

Fiamma Peruginelli

3

1 reference

30 November 2017

Domenico E Pellegrini-Giampietro

4

1 reference

30 November 2017

Flavio Moroni

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Journal of Neurochemistry

30 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

volume

82

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

1465-1471

1 reference

Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Presynaptic kynurenate-sensitive receptors inhibit glutamate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Presence of Kynurenic Acid in the Mammalian Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Quinolinic acid and other kynurenines in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Identification and quantification of kynurenic acid in human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.01090.X

10.1046/J.1471-4159.2002.01090.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference